20
Feb
2018
Van Andel Research Institute Chief Scientific Officer awarded honorary doctorate
GRAND RAPIDS, Mich. (Feb 20, 2018)—Van Andel Research Institute (VARI) Chief Scientific Officer Peter Jones, Ph.D., D.Sc., will be awarded an honorary... Read More
12
Oct
2017
A Catalyst for combating cancer
/
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr.... Read More
15
Jun
2017
VARI’s Chief Scientific Officer won an Outstanding Investigator Award. Here’s what that means.
/
VARI’s Chief Scientific Officer Peter Jones, Ph.D., D.Sc., has received a highly competitive 7-year, $7.8 million Outstanding Investigator Award grant from the... Read More
13
Jun
2017
VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers
International collaboration pairs immunotherapy with an epigenetic drug to stop progression of chronic myelomonocytic leukemia and myelodysplastic syndrome into acute myeloid leukemia... Read More
29
Aug
2016
Vitamin C may boost effectiveness of acute myeloid leukemia treatment
/
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any... Read More
24
Feb
2014
Van Andel INSTITUTE ESTABLISHES GLOBAL EPIGENETICS RESEARCH HUB, BECOMING STRONGHOUSE FOR HOT TOPIC IN CANCER RESEARCH
/
World-Renowned Molecular Biologist and New Director of Research, Chief Scientific Officer Dr. Peter Jones Leading Translational Research in Epigenetics Grand Rapids, Mich.... Read More
16
Dec
2013
VAN ANDEL INSTITUTE APPOINTS NEW DIRECTOR OF RESEARCH, CHIEF SCIENTIFIC OFFICER
/
World-Renowned Molecular Biologist to Help Shape Future of Research Institute Grand Rapids, Mich. (Dec. 16, 2013) – Van Andel Institute, a world-class research... Read More